Sex hormone affects the severity of non-alcoholic steatohepatitis through the MyD88-dependent IL-6 signaling pathway

Experimental Biology and Medicine

Volumn 240, Issue 10, 2015, Pages 1279-1286

  Xin, Guangda ^a   Qin, Shaoyou ^a   Wang, Song ^b   Wang, Xu ^a   Zhang, Yonggui ^a   Wang, Jiangbin ^a  

^a CHINA JAPAN UNION HOSPITAL OF JILIN UNIVERSITY   (China)

^b THE SECOND HOSPITAL OF JILIN UNIVERSITY   (China)

Author keywords

Non alcoholic steatohepatitis; Sex hormone specific intervention; Sex associated differences; TLR MyD88 IL 6 signaling pathway

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BETA ACTIN; ESTRADIOL; ESTRADIOL BENZOATE; INTERLEUKIN 6; MESSENGER RNA; MYELOID DIFFERENTIATION FACTOR 88; TESTOSTERONE; TESTOSTERONE PROPIONATE; ANDROGEN; ESTROGEN; MYD88 PROTEIN, MOUSE; SEX HORMONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD ANALYSIS; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; INFLAMMATION; MALE; MOUSE; NONALCOHOLIC FATTY LIVER; NONALCOHOLIC FATTY LIVER DISEASE ACTIVITY SCORE; NONHUMAN; OPTICAL DENSITY; ORCHIECTOMY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEX ROLE; SIGNAL TRANSDUCTION; WESTERN BLOTTING; ANIMAL; BLOOD; C57BL MOUSE; DRUG EFFECTS; LIVER; METABOLISM; PATHOLOGY;

ALANINE TRANSAMINASE; ANDROGENS; ANIMALS; ASPARTATE AMINOTRANSFERASES; ESTROGENS; FEMALE; GONADAL STEROID HORMONES; INTERLEUKIN-6; LIVER; MALE; MICE, INBRED C57BL; MYELOID DIFFERENTIATION FACTOR 88; NON-ALCOHOLIC FATTY LIVER DISEASE; RNA, MESSENGER; SIGNAL TRANSDUCTION; TESTOSTERONE;

EID: 84942854090     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.1177/1535370215570189     Document Type: Article

References (37)

1. W.L.AlwardB.J.McMahonD.B.HallW.L.HeywardD.P.FrancisT.R.Bender. The long-term serological course of asymptomatic hepatitis B virus carriers and the development of primary hepatocellular carcinoma. J Infect Dis1985; 151(4): 604–9.
2. Y.YokoyamaY.NimuraM.NaginoK.I.BlandI.H.Chaudry. Current understanding of gender dimorphism in hepatic pathophysiology. J Surg Res2005; 128(1): 147–56.
3. G.FattovichL.BrolloG.GiustinaF.NoventaP.PontissoA.AlbertiA.AlbertiG.RealdiA.Ruol. Natural history and prognostic factors for chronic hepatitis type B. Gut1991; 32(3): 294–8.
4. M.W.YuY.C.YangS.Y.YangS.W.ChengY.F.LiawS.M.LinC.J.Chen. Hormonal markers and hepatitis B virus-related hepatocellular carcinoma risk: A nested case-control study among men. J Natl Cancer Inst2001; 95(7): 559–60.
5. N.FurusyoJ.HayashiY.SawayamaY.KishiharaS.Kashiwagi. Hepatitis B surface antigen disappearance and hepatitis B surface antigen subtype: A prospective, long-term, follow-up study of Japanese residents of Okinawa, Japan with chronic hepatitis B virus infection. Am J Trop Med Hyg1999; 60(4): 616–22.
6. S.KashiwagiJ.HayashiH.IkematsuH.NomuraT.KusabaT.ShinguK.HayashidaM.Kaji. An epidemiologic study of hepatitis B virus in Okinawa and Kyushu, Japan. Am J Epidemiol1983; 118(6): 787–94.
7. U.BeckerA.DeisT.I.SørensenM.GrønbaekK.Borch-JohnsenC.F.MüllerP.SchnohrG.Jensen. Prediction of risk of liver disease by alcohol intake, sex, and age: A prospective population study. Hepatology1996; 23(5): 1025–9.
8. M.J.AshleyJ.S.OlinW.H.le RicheA.KornaczewskiW.SchmidtJ.G.Rankin. Morbidity in alcoholics. Evidence for accelerated development of physical disease in women. Arch Intern Med1977; 137(7): 883–7.
9. H.B.El-SeragK.L.Rudolph. Hepatocellular carcinoma: Epidemiology and molecular carcinogenesis. Gastroenterology2007; 132(7): 2557–76.
10. J.A.WelshS.KarpenM.B.Vos. Increasing prevalence of nonalcoholic fatty liver disease among United States adolescents, 1988–1994 to 2007–2010. J Pediatr2013; 162(3): 496–500.
11. J.G.FanF.LiX.B.CaiY.D.PengQ.H.AoY.Gao. The importance of metabolic factors for the increasing prevalence of fatty liver in Shanghai factory workers. J Gastroenterol Hepatol2007; 22(5): 663–8.
12. Z.WangB.XiaC.MaZ.HuX.ChenP.Cao. Prevalence and risk factors of fatty liver disease in the Shuiguohu district of Wuhan city, central China. Postgrad Med J2007; 83(977): 192–5.
13. E.HashimotoK.Tokushige. Prevalence, gender, ethnic variations, and prognosis of NASH. J Gastroenterol2011; 46(Suppl 1): 63–9.
14. S.YatsujiE.HashimotoM.TobariK.TokushigeK.Shiratori. Influence of age and gender in Japanese patients with non-alcoholic steatohepatitis. Hepatol Res2007; 37(12): 1034–43.
15. R.KirschV.ClarksonE.G.ShephardD.A.MaraisM.A.JafferV.E.WoodburneR.E.KirschL.Hall Pde. Rodent nutritional model of non-alcoholic steatohepatitis: Species, strain and sex difference studies. J Gastroenterol Hepatol2003; 18(11): 1272–82.
16. A.SprussJ.HenkelG.KanuriD.BlankG.P.PüschelS.C.BischoffI.Bergheim. Female mice are more susceptible to nonalcoholic fatty liver disease: Sex-specific regulation of the hepatic AMP-activated protein kinase-plasminogen activator inhibitor 1 cascade, but not the hepatic endotoxin response. Mol Med2012; 18: 1346–55.
17. Y.AnezakiS.OhshimaH.IshiiN.KinoshitaT.DohmenE.KataokaW.SatoM.lizukaT.GotoJ.SasakiT.SasakiA.SuzukiH.OhnishiY.Horie. Sex difference in the liver of hepatocyte-specific Pten-deficient mice: A model of nonalcoholic steatohepatitis. Hepatol Res2009; 39(6): 609–18.
18. N.E.DaryaniN.E.DaryaniS.M.AlavianA.ZareS.M.FereshtehnejadM.R.KeramatiM.R.PashaeiP.Habibollahi. Non-alcoholic steatohepatitis and influence of age and gender on histopathologic findings. World J Gastroenterol2010; 16(33): 4169–75.
19. Y.KamadaS.KisoY.YoshidaN.ChataniT.KizuM.HamanoM.TsubakioT.TakemuraH.EzakiN.HayashiT.Takehara. Estrogen deficiency worsens steatohepatitis in mice fed high-fat and high-cholesterol diet. Am J Physiol Gastrointest Liver Physiol2011; 301(6): G1031–43.
20. P.R.KashireddyM.S.Rao. Sex differences in choline-deficient diet-induced steatohepatitis in mice. Exp Biol Med (Maywood)2004; 229(2): 158–62.
21. G.X.TianY.SunC.J.PangA.H.TanY.GaoH.Y.ZhangX.B.YangZ.X.LiZ.N.Mo. Oestradiol is a protective factor for non-alcoholic fatty liver disease in healthy men. Obes Rev2012; 13(4): 381–7.
22. Y.MuR.SheH.ZhangB.DongC.HuangW.LinD.LiX.Li. Effects of estrogen and androgen deprivation on the progression of non-alcoholic steatohepatitis (NASH) in male Sprague-Dawley rats. Hepatol Res2009; 39(9): 910–20.
23. H.ZhangY.LiuL.WangZ.LiH.ZhangJ.WuN.RahmanY.GuoD.LiN.LiI.HuhtaniemiS.Y.TsangG.F.GaoX.Li. Differential effects of estrogen/androgen on the prevention of nonalcoholic fatty liver disease in the male rat. J Lipid Res2013; 54(2): 345–57.
24. W.E.NauglerT.SakuraiS.KimS.MaedaK.KimA.M.ElsharkawyM.Karin. Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production. Science2007; 317(5834): 121–4.
25. E.MasM.DanjouxV.GarciaS.CarpentierB.SéguiT.Levade. IL-6 deficiency attenuates murine diet-induced non-alcoholic steatohepatitis. PLoS One2009; 4(11): e7929–e7929.
26. K.YamaguchiY.ItohC.YokomizoT.NishimuraT.NiimiH.FujiiT.OkanoueT.Yoshikawa. Blockade of interleukin-6 signaling enhances hepatic steatosis but improves liver injury in methionine choline-deficient diet-fed mice. Lab Invest2010; 90(8): 1169–78.
27. K.YamaguchiY.ItohC.YokomizoT.NishimuraT.NiimiA.UmemuraT.OkanoueT.Yoshikawa. Blockade of IL-6 signaling exacerbates liver injury and suppresses antiapoptotic gene expression in methionine choline-deficient diet-fed db/db mice. Lab Invest2011; 91(4): 609–18.
28. Y.S.RohE.Seki. Toll-like receptors in alcoholic liver disease, non-alcoholic steatohepatitis and carcinogenesis. J Gastroenterol Hepatol2013; 28(Suppl 1): 38–42.
29. G.C.FarrellD.van RooyenL.GanS.Chitturi. NASH is an inflammatory disorder: Pathogenic, prognostic and therapeutic implications. Gut Liver2012; 6(2): 149–71.
30. M.HiratsukaT.MatsuuraE.WatanabeM.SatoY.Suzuki. Sex and strain differences in constitutive expression of fatty acid ω-hydroxylase (CYP4A-related proteins) in mice. J Biochem1996; 119(2): 340–5.
31. D.E.KleinerE.M.BruntM.Van NattaC.BehlingM.J.ContosO.W.CummingsL.D.FerrellY.C.LiuM.S.TorbensonA.Unalp-AridaM.YehA.J.McCulloughA.J.Sanyal. Nonalcoholic steatohepatitis clinical research network. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology2005; 41(6): 1313–21.
32. E.J.TheveY.FengK.TaghizadehK.S.CormierD.R.BellJ.G.FoxA.B.Rogers. Sex hormone influence on hepatitis in young male A/JCr mice infected with Helicobacter hepaticus. Infect Immun2008; 76(9): 4071–8.
33. T.KaishoS.Akira. Toll-like receptor function and signaling. J Allergy Clin Immunol2006; 117(5): 979–87.
34. N.SuzukiS.SuzukiG.S.DuncanD.G.MillarT.WadaC.MirtsosH.TakadaA.WakehamA.ItieA.ItieS.LiJ.M.PenningerH.WescheP.S.OhashiT.W.MakW.C.Yeh. Severe impairment of interleukin-1 and Toll-like receptor signalling in mice lacking IRAK-4. Nature2002; 416(6882): 750–6.
35. P.G.MotshweneM.C.MoncrieffeJ.G.GrossmannC.KaoM.AyaluruA.M.SandercockC.V.RobinsonE.LatzN.J.Gay. An oligomeric signaling platform formed by the Toll-like receptor signal transducers MyD88 and IRAK-4. J Biol Chem2009; 284(37): 25404–11.
36. H.KonnoT.YamamotoK.YamazakiJ.GohdaT.AkiyamaK.SembaH.GotoA.KatoT.YujiriT.ImaiY.KawaguchiB.SuO.TakeuchiS.AkiraY.Tsunetsugu-YokotaJ.Inoue. TRAF6 establishes innate immune responses by activating NF-kappaB and IRF7 upon sensing cytosolic viral RNA and DNA. PLoS One2009; 4(5): e5674–e5674.
37. S.SatoH.SanjoK.TakedaJ.Ninomiya-TsujiM.YamamotoT.KawaiK.MatsumotoO.TakeuchiS.Akira. Essential function for the kinase TAK1 in innate and adaptive immune responses. Nat Immunol2005; 6(11): 1087–95.